Clinical and laboratory observationProtective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate*
References (14)
- et al.
Specific antibodies of diphtheria toxin and type 6A pneumococcal capsular polysaccharide induced by a model of semi-synthetic glycoconjugate antigen
Mol Immunol
(1985) - et al.
Clinical and immunological responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children
J Pediatr
(1988) - et al.
- et al.
Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20, an oligosaccharide-protein conjugate vaccine
J Pediatr
(1987) - et al.
Preparation, characterization and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates
J Exp Med
(1980) - et al.
Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates
Infect Immun
(1983) Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM 197
Infect Immun
(1983)
Cited by (81)
Carrier priming or suppression: Understanding carrier priming enhancement of anti-polysaccharide antibody response to conjugate vaccines
2014, VaccineCitation Excerpt :Booy et al. [41] found that early immunization schedule of DTP resulted in a significantly lower immune response than a later one, which suggest that with an accelerated schedule, maternal antibodies can have an inhibitory effect on the responses to immunization against tetanus and pertussis. However, the inhibitory effects of passively acquired maternal TT antibodies on the antibody response to HibV-TT was demonstrated in a RCT [42], such effects were not seen if infants were primed with TT one month prior to immunization with HibV-TT in other observational studies [25,43,44]. There are several RCTs comparing different immunization schedules for PCV in infants in terms of timing and number of doses.
Antibody response to Haemophilus influenzae type b tetanus conjugate vaccine with two doses given at 3 and 5 months of age
2002, International Journal of Infectious Diseases
- *
The clinical protocol, information sheet and consent form (84-CH-109), and vaccine standardization data (BBIND 1977) for this study were reviewed by the Medical Board of the National Institutes of Health, U.S. Food and Drug Administration, the Ethical Committee of the University of Gothenburg, and the Drug Department of the Swedish Board of Health and Welfare.